Yoram Reiter

This inventor holds 20 USPTO granted patents and 16 published patent applications, plus 2 CIPO patents and 11 EPO patents, primarily in Antibody Engineering. Top assignees: Technion Research & Development Foundation Ltd, Teva Pharmaceutical Industries Limited, Adicet Therapeutics, Inc.. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoram Reiter. Retrieved from https://idiyas.com/inventor/yoram-reiter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 16)

% Patents Active = 30.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 16)

Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 83(Granted Patents)

Company Filing History:

17 out of 1,005

Technion Research & Development Foundation Ltd

patents

2 out of 505

Teva Pharmaceutical Industries Limited

patents

1 out of 6

Adicet Therapeutics, Inc.

patents

4. 1 out of 131

Tel Hashomer Medical Research Infrastructure and Services Ltd.

patents

5. 2 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Affinity Entities

TCR-like Antibodies

MHC Class II

Antigen-Presenting Complex

Immuno-Molecules

Fusion Proteins

Single Chain Class I

Antibody Fragments

Viral Proteins

Cancer Detection

Autoimmune Disease

HLA-A2 Binding

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12252547 - Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same (2025-03-18),

2. 11485785 - Antibodies capable of binding HLA-A2/TyrD in an HLA restricted manner and uses thereof (2022-11-01),

3. 11001642 - Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same (2021-05-11),

4. 9695410 - Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides (2017-07-04),

5. 9616112 - Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof (2017-04-11),

6. 9095533 - Antigen-presenting complex-binding compositions and uses thereof (2015-08-04),

7. 9023348 - Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof (2015-05-05),

8. 8747855 - Anti human immunodeficiency antibodies and uses thereof (2014-06-10),

9. 8541185 - Method of predicting responsiveness to autologous adoptive cell transfer therapy (2013-09-24),

10. 8449889 - Immuno-molecules containing viral proteins, compositions thereof and methods of using (2013-05-28),

11. 8361473 - Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases (2013-01-29),

12. 8354066 - Artificial receptors (2013-01-15),

13. 8022190 - Immuno-molecules containing viral proteins, compositions thereof and methods of using (2011-09-20),

14. 7977457 - Fusion proteins, uses thereof and processes for producing same (2011-07-12),

15. 7718777 - MHC-peptide complex binding ligands (2010-05-18),

Title: Yoram Reiter: Pioneering Inventor from Haifa, Israel

Introduction: Yoram Reiter is a distinguished inventor hailing from the vibrant city of Haifa, Israel. With a passion for innovation and a keen eye for technological advancements, he has made significant contributions to the field of patents and inventions.

Latest Patents: Yoram Reiter's latest patents showcase his expertise in cutting-edge technologies, including advancements in renewable energy, artificial intelligence, and medical devices. His innovative solutions have garnered attention worldwide for their potential to revolutionize various industries.

Career Highlights: Throughout his illustrious career, Yoram Reiter has been recognized for his groundbreaking inventions that have pushed the boundaries of what is possible. His commitment to excellence and relentless pursuit of innovation have earned him a reputation as a trailblazer in the field of patents.

Collaborations: Yoram Reiter has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful development and commercialization of several groundbreaking technologies.

Conclusion: Yoram Reiter's passion for innovation, coupled with his exceptional talent for inventing, has solidified his position as a prominent figure in the world of patents. His contributions continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.